期刊
MEDICAL ONCOLOGY
卷 28, 期 3, 页码 682-688出版社
HUMANA PRESS INC
DOI: 10.1007/s12032-010-9515-2
关键词
NSCLC; Dendritic cells (DC); Programmed-death receptor ligands 1 (PD-L1); CD83; CD1 alpha
类别
资金
- National Natural Science Foundation of China [30770947]
- 135 Projects focus on Talent Foundation of Health Department of Jiangsu Province [RC2007075]
- Medical Development Foundation of Jiangsu Province [H200712]
The immunohistochemical analysis was used to evaluate the expression of PD-L1 in 109 non-small cell lung cancer (NSCLC) tissues and para-tumor tissues. Associations between expressed PD-L1 and tumor histological types, degree of differentiation, and lymph node metastasis were calculated, and overall survival was assessed. Meanwhile, immunohistochemistry and immunofluorescence double labeling technique were performed to detect the expressions of PD-L1, CD1 alpha, and CD83 on TIDC of 20 lung cancer tissues, and the expression of PD-L1 in CD1 alpha(+)DCs and CD83(+)DCs and their significances were also explored. We found that the expression rate of PD-L1 in NSCLC was associated with histological types and overall survival. Patients with either adenocarcinoma or survival time after surgery less than 3 years showed higher expression rate of PD-L1. Furthermore, Cox model analysis indicated that PD-L1 might be regarded as a poor prognostic factor. PD-L1 could be also detected in CD1 alpha(+) immature DC in NSCLC, indicating that as a class of key anti-tumor immunocyte in tumor microenvironment, DC expressing PD-L1 itself might play an important role in keeping its immature status and contributing to tumor cells immune escape and disease progression.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据